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Abstract
Background: Plasmodium falciparum merozoites are free invasive forms that invade host erythrocytes in iterative
cycles in the presence of different arms of the immune system. Variant antigens are known to play a role in
immune evasion and several gene families coding for variant antigens have been identified in P. falciparum.
However, none of them have been reported to be expressed on the surface of merozoites.
Methods: Flow cytometry, immunofluorescence microscopy, and immunoblotting assays were performed to assess
surface exposure, membrane association and stage specific expression of the STEVOR family of variants proteins,
respectively.
Results: Using a polyclonal antibody (anti-PFL2610w) with a broad specificity towards different STEVOR variants,
the STEVOR proteins were identified on the surface of non-permeabilized/non-fixed merozoites in flow cytometry
assays. Anti-PFL2610w antibody showed that several STEVORs were expressed in the trophozoite stage of the
parasite but only one variant was integrated into the merozoite membrane. Moreover, this antibody failed to
identify STEVORs on the surface of the parent schizont infected erythrocytes (IE) although they were readily
identified when schizont IE were permeabilized.
Conclusions: These data suggest for a role for STEVOR in immune evasion by P. falciparum merozoites to allow
successful invasion of erythrocytes. Additionally, the expression of STEVORs in the schizont stage may only
represent a step in the biogenesis process of the merozoite surface coat.
Background
Of the four species causing human malaria, Plasmodium
falciparum is the most dangerous. It causes the highest
rates of complications and mortality in the tropical and
subtropical regions worldwide. It was estimated for the
year 2002 that about 500 million people suffered from
P. falciparum-malaria and about one million died [1].
The remarkable ability of the P. falciparum parasite to
achieve this in comparison to other Plasmodium species
is due to its capability to infect all ages of human ery-
throcytes leading to a higher parasite load. Additionally,
the P. falciparum trophozoite and schizont IE stages
have a unique competence to cytoadhere to a variety of
human endothelia to escape from the circulation and
avoid clearance by the spleen until merozoites become
released and invade new erythrocytes. In malaria
endemic areas, immunity develops against mild or
uncomplicated P. falciparum malaria over a long period
of time during which individuals are repeatedly infected
with the parasite. On the other hand, immunity against
severe forms of malaria such as severe anaemia and cer-
ebral malaria take shorter periods to develop. A broad
immunity to most forms of malaria is reached at adult-
hood and declines when an individual leaves the ende-
mic area [2-4]. Despite acquiring immunity to malaria,
the parasite persists and causes an asymptomatic infec-
tion in adults living in areas where malaria is endemic.
Thus infected adults serve as a reservoir for the parasite
in hyperendemic areas where malaria is seasonal and
mosquitoes disappear during the dry seasons.
Successful merozoite invasion of new erythrocytes in
the iterative growth cycle of the P. falciparum parasites is
a prerequisite for parasite persistence in adults in ende-
mic areas. This appears to occur despite acquiring immu-
nity that limits both severe and mild forms of malaria. It
also indicates that the parasite must have effective tools
to complete the invasion steps (attachment, reorientation,
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engulfment and entry) without being harmed by the
immune system. Proteins that possess highly variable
sequences and encoded by multi-copy gene families are
lead candidates for such tools. The var, rif and stevor are
known P. falciparum multi-copy gene families that
undergo antigenic variation [5], they could thus be
involved in merozoite escape from the immune system
attack.
STEVORs encoded by the stevor gene family are the
most widely expressed variant antigens in the different
stages of the P. falciparum parasite. They were found in
the late trophozoite and schizont IE stages in flattened
vesicular structures known as Maurer’s clefts (MC) loca-
lized in the erythrocyte cytoplasm [6]. Further studies
localized STEVORs to the IE membrane by electron
microscopy [7,8] or to the IE surface by flow cytometry
[9]. STEVORs were also detected in the gametocyte and
sporozoite stages of the parasite [10]. The stevor family
is represented by 39 members in the 3D7 genome [11].
stevor gene transcription peaks at the mid-trophozoite
stage [6], 28 h post invasion (p.i.) and only a subset of
stevor genes are transcribed at any given time in a
population of parasites [12]. Evidence for clonal varia-
tion in stevor expression was reported at the transcrip-
tion level [12] and at the protein level [8,9]. STEVORs
share protein architecture with proteins encoded by the
rif and the Pfmc-2TM families and altogether constitute
what is described as the TM superfamily [13]. This
architecture consists of a signal sequence, a hypervari-
able (HV) region surrounded by two predicted trans-
membrane domains and a cytoplasmic tail. The HV
region is of varying length and up to 170 and 60 amino
acid residues in RIFINs and STEVORs, respectively and
only three residues, on average, in the Pfmc-2TM family
[13]. Members of the TM superfamily have no known
function so far. In recent work evidence was presented
by our group for the expression of STEVORs in the
merozoite stage of the P. falciparum parasite. Immuno-
fluorescence and immunoelectron microscopy localized
STEVORs to the surface coat of the merozoites and to
the rhoptries [8]. Localization of STEVORs to the rhop-
tries was also shown in a different study [14]. These
data suggest that the parasite might utilize STEVORs
expressed in the merozoite stage to vary antigenically as
a means to establish a long-lasting persistent infection
together with similar or different strategies in the other
stages of the parasites. Since the accessibility of the var-
iant antigen to the surface of the cell is an important
feature in mediating immune evasion, a follow-up study
was conducted to verify the exposure of STEVORs on
the merozoite surface.
Here, a polyclonal anti-STEVOR antibody (anti-
PFL2610w) identified STEVOR(s) on the surface of mer-
ozoites in flow cytometry assays. Similar variants were
identified by the same antibody also in the parent schi-
zont IE, but not on the surface of the intact schizont IE.
Western blot analyses of protein extracts from early
ring, mid-trophozoite and merozoite stages of the para-
site provided evidence on the over-expression of a single
STEVOR variant in merozoites. These data strengthen
the suggested role of STEVORs in mediating immune
evasion by the merozoites to acquire a long lasting cap-
ability of invading host erythrocytes.
Methods
Parasite strain and culture
The P. falciparum strain used in this study was the 3D7
parasite line. It was cultured in O+ human erythrocytes
at 5% haematocrit in RPMI-1640 medium supplemented
with 0.5% Albumax II (Gibco, Carlsbad, CA, USA),
200 μM hypoxanthine (Sigma, St. Louis, MO, USA) and
20 μg/mL gentamycin (Gibco).
Anti-STEVOR antibody
Mouse polyclonal Anti-STEVOR antibody was generated
[15] against a recombinant STEVOR that included both
the hypervariable and the conserved region of the
PFL2610w stevor gene (Figure 1). Amino acid boundaries
of the recombinant protein are described elsewhere [15].
Schizont IE enrichment and isolation of free P. falciparum
merozoites
Erythrocytes infected with P. falciparum ring stages
were synchronized twice, 4 h apart, by sorbitol treat-
ment (Sigma, St. Louis, MO, USA), grown to high para-
sitaemia (≈ 10%) of mostly schizonts and enriched to a
parasitaemia of about 90 - 95% by magnet-activated cell
sorting (MACS). To prepare naturally released mero-
zoites, 44-48 hour (p.i.) schizont IE were purified by
MACS and placed back into culture at 1% haematocrit
in RPMI-1640 complete medium (P. falciparum culture
medium). Every 90 min the culture was examined by
microscopy for schizont IE rupture and merozoite
release. When the majority of schizont IE had ruptured,
free haemozoin, intact schizont IE and uninfected ery-
throcytes were removed by centrifugation for 4 min at
600 × g at room temperature followed by a single step
of purification by passage through the MACS column.
Finally, merozoites were pelleted from the flow through
Figure 1 Domain architecture of the STEVOR protein family.
The recombinantly expressed STEVOR used to produce the anti-
PFL2610w antibody is delineated by the arrows. Abbreviations:
signal peptide (SP), conserved region (CR), hypervariable region (HR),
transmembrane domain (TM) and cytoplasmic tail (CT).
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by centrifugation for 15 min at 2880 × g at 4°C, and
washed once in PBS. Merozoite integrity was checked
by Giemsa staining. Merozoites used in immunoblotting
were further purified by double filtering through 3 μm
and 1.2 μm Versapor membranes and pelleted by centri-
fugation for 15 min at 2880 × g at 4°C.
Immunofluorescence and colocalization assays
For indirect immunofluorescence microscopy, parasites
were cultured and synchronized as described above and
allowed to grow for one cycle before samples were pro-
cessed. IE representing the schizont stage were smeared
on glass slides, air-dried and fixed for 5 min with ice-
cold methanol. Smears were blocked with PBS/1% BSA
for 30 min at room temperature. Slides were washed
once in PBS/0.05% Tween 20 for 5 min and incubated
at room temperature for 2 h with mouse anti-PFL2610w
antibody (1:500) or a mix of mouse anti-PFL2610w anti-
body (1:500) and rabbit anti-MSP1 antibody (1:200) in
PBS/1% BSA. Slides were then washed 3 × 5 min in
PBS/0.05% Tween 20. Binding of the primary antibodies
was visualized by Alexa 488-conjugated goat anti-mouse
IgG (1:1000; Molecular Probes) when anti-PFL2610w
antibody was solely used, whereas a mixture of Alexa
488-conjugated goat anti-mouse (1:1000; Molecular
Probes) and Alexa 546-conjugated goat anti-rabbit
(1:1000; Molecular Probes) were used when combining
the analysis of both anti-PFL2610w and anti-MSP1
primary antibodies. Cell nuclei were visualized by
DAPI (4’,6-diamidino-2-phenylindole) (5 μg/ml; Roth,
Germany). Slides were mounted on MOWIOL (Calbio-
chem, San Diego, CA, USA), viewed with the Olympus
BX51 fluorescence microscope and images were cap-
tured using the Olympus DP70 camera with the help of
DP controller software. Pre-immune sera were used to
replace the anti-PFL2610w antibody for the negative
control slides.
Flow cytometry assays
Enriched schizont IE and purified free merozoites were
tested for recognition of their surface by the anti-
PFL2610w antibody. Schizont IE and merozoite prepara-
tions were diluted to approximately 5 × 106 cells/ml in
PBS/1% BSA. Nuclei of both stages were stained with
20 μl ethidium bromide (0.1 mg/ml in PBS) per ml of
cell suspension. The anti-PFL2610w antibody and the
pre-immune serum were diluted to 1:400 in 100 μl of
cell suspensions and incubated at 4°C for 1 hr. Schizont
IE and merozoites were then washed twice in 1.5 ml
PBS/1% BSA and pelleted after each wash by centrifuga-
tion at 4°C for 5 min at 800 × g and 6000 × g, respec-
tively. Schizont IE and merozoites were resuspended in
100 μl Alexa 488-conjugated goat anti-mouse diluted to
1:500 in PBS/1% BSA and incubated at 4°C for 1 hr and
then washed as above. Stained schizont IE and mero-
zoites were resuspended in 200 μl PBS/1% BSA and ana-
lysed using the FACScan flow cytometer. Flow
cytometry assays on permeabilized schizont IE were also
performed. Treatment of packed schizont IE with 10
volume of 0.05% saponin in PBS for 10 min on ice ren-
ders the erythrocyte membrane freely permeable to
solutes as large as soluble proteins (e.g. antibodies). Per-
meabilized schizont IE were washed thrice with the per-
meabilization buffer, pelleted after each wash by
centrifugation at 3000 × g for 5 min at 4°C and treated
with the same flow cytometry staining protocol as
described above. Buffers used for primary and secondary
antibody incubation and for washing included 0.05%
saponin.
Western blot analysis
Merozoite and saponin permeabilized early ring-IE (8-12
h) and mid-trophozoite-IE (24-30 h) stages representing
a single growth cycle of the synchronized parasite were
analysed by immunoblotting for the determination of
STEVOR expression pattern. Trophozoite-IE and ring-
IE stages were permeabilized as described above and the
final pellets were boiled in 1× SDS sample buffer for
10 min. A fraction of each protein extract was loaded
onto SDS-polyacrylamide gels and separated proteins
were transferred to Trans-Blot transfer medium mem-
brane (Bio-Rad, Hercules, CA, USA). The presence of
erythrocyte membranes in each protein extract prepara-
tion was monitored with anti-glycophorin A antibody
(abcam, USA). The membranes were probed with either
anti-PFL2610w antibody or the pre-immune serum.
Reactivity was visualized by goat anti-mouse IgG
coupled to horseradish peroxidase (1:30 000; Pierce,
Rockford, IL, USA). Blots were developed by the
enhanced chemiluminescent (ECL Western blot analysis
system)-based detection according to the manufacturer’s
instructions (GE Healthcare, Life Sciences, Bucks, UK)
followed by exposure to Super RX films (Fujifilm). Blots
were imaged and bands were quantified by densito-
metric analysis of band intensity using Kodak 1 D v.
3.5.3 software (Kodak Scientific Imaging Systems).
Results
Infected erythrocytes permeabilization is required for
STEVOR recognition by the anti-PFL2610w antibody in
flow cytometry assays
The predicted secondary structure characteristics of
STEVORs suggest that STEVORs’ hypervariable region
could acquire cell surface location and be exposed to
the immune system at some stages during infection.
Thus, STEVORs are speculated to be involved in anti-
genic variation and host parasite interaction, biological
functions that are well described for the IE surface
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protein, PfEMP1. This is known to mediate cytoadhe-
sion and immune evasion in P. falciparum infection.
Earlier reports showed expression of STEVORs in the IE
as well as other stages of the parasite. More recent stu-
dies have shown the expression of STEVORs at the api-
cal end of the merozoites in immunofluorescence
microscopy and on the surface of IE using flow cytome-
try assays and STEVOR variant-specific antibodies
[9,14]. In our parallel effort to link the predicted protein
organization of STEVORs with the biology and patho-
genesis of the parasite, STEVORs were shown to be
associated with the surface of merozoites [8]. STEVORs
were also detected as released proteins from the mero-
zoites during erythrocyte invasion [8]. These findings
prompted us to ask whether the variant specific anti-
body that was used to localize STEVORs at the mero-
zoite membrane can identify STEVORs on the surface
of the parent schizont IE or a biologically relevant
stage-specific differential expression is taking place.
Thus, enriched non-permeabilized/non-fixed 3D7 schi-
zont IE were analysed in flow cytometry assays using
the antibody that we have produced against a specific
STEVOR variant (PFL2610w). This antibody is capable
of recognizing STEVORs associated with the merozoite
membrane. Minimal binding of anti-PFL2610w antibody
to the surface of schizont IE was observed as indicated
by the slight shift in the relative fluorescence intensity
compared to the basal level binding of the pre-immune
serum antibodies (Figure 2A, lower panel). This was
confirmed by immunofluorescence microscopy on the
same preparation (Figure 2A, upper panel). Additionally,
the immunofluorescence microscopy showed some
green fluorescent staining that did not overlay well with
the nuclear staining. This probably represented a popu-
lation of ruptured cells. This matched the dot blot quad-
rant statistics showing an increase in the ethidium
bromide/Alexa-488 double stained population from
2.17% with pre-immune serum to 3.86% with the anti-
PFL2610w antibody (dot plot figure not shown). This
observation prompted us to ask whether the anti-
PFL2610w antibody could recognize intact cells if they
are permeabilized, a condition close to cell rupture.
Consequently, schizont IE were permeabilized by 0.05%
saponin and the staining protocol was repeated as
before but with the exception that 0.05% saponin was
present in all solutions. Staining protocol was also per-
formed on non-permeabilized schizont IE to control for
possible generation of specific variations in the
expressed STEVORs. Interestingly, flow cytometry analy-
sis of this preparation showed a striking shift in the rela-
tive fluorescence intensity compared to the pre-immune
serum (Figure 2B, lower panel). The same preparation
was also analysed by immunofluorescence microscopy
and schizont IE staining with anti-PFL2610w was
confirmed (Figure 2B, upper panel). On the other hand,
the anti-PFL2610w antibody still did not bind to the
non-permeabilized schizont IE. In conclusion, these
findings indicated that the anti-PFL2610w can only
recognize STEVOR variants that are associated with
internal schizont IE structures but not those presumably
expressed on the surface.
STEVOR is expressed on the surface of merozoites
Next we wanted to study whether anti-PFL2610w anti-
body can recognize STEVORs in merozoites released
from schizont IE that were used for the flow cytometry
assay and did not show any surface labelling. A fraction
of this schizont IE preparation was allowed to naturally
rupture and release merozoites. Subsequently, binding
of anti-PFL2610w antibody to merozoite membranes
was assessed by immunofluorescence microscopy using
methanol fixed merozoite slides. Remarkably, anti-
PFL2610w antibody that failed to recognize the surface
of non-permeabilized schizont IE in flow assays readily
recognized the membranes of fixed merozoites in
immunofluorescence microscopy (Figure 3). Moreover,
an antibody to the well described merozoite surface
protein (MSP-1) showed that both proteins occupy the
same location (Figure 3). Additionally, recognition of
STEVOR variant(s) in the merozoite membrane by this
antibody clearly showed the association of STEVORs
with the merozoite surface membrane. However, it
remained unclear whether STEVORs were exposed
on the surface or not, a location suspected for an
antigen with such domain organization like STEVOR.
To further clarify these points freshly isolated non-
permeabilized/non-fixed merozoites (purity of the
preparation is shown in Figure 4A) were probed with
anti-PFL2610w antibody and the bound antibodies were
visualized by anti-mouse Alexa-488 conjugated anti-
body. Interestingly, anti-PFL2610w antibody bound to
the surface of merozoites represented as the Ethidium
bromide/Alexa 488 double stained population (Figure
4C, lower panel). Antibodies in the pre-immune serum
did not show any significant binding to the merozoite
surface (Figure 4B, lower panel) supporting the specifi-
city of the anti-PFL2610w binding. Altogether, these
data showed that anti-PFL2610w could not recognize
STEVOR on the surface of the schizont IE, but rather
in internal structures. Moreover, STEVORs were readily
indentified on the merozoites surface upon their release
from the schizont IE.
Over-expression of a single STEVOR in merozoites
Anti-PFL2610w was generated against a recombinant
protein that included both the variable variant specific
sequence and the semi-conserved STEVOR family speci-
fic sequence (Figure 1). This antibody was successfully
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used to study clonal variation of STEVOR expression in
NF54-derived lines in relation to their binding capacity
to chondroitin sulphate A and CD36 receptors and sub-
sequent loss of these phenotypes [8]. Therein, several
STEVOR variants were identified at the late trophozoite
stage by the anti-PFL2610w antibody in Western blot
analyses. Moreover, the antibody identified STEVOR
expression in the ring, trophozoite, schizont and mero-
zoite stage parasites in immunofluorescence microscopy.
The former data and the new finding on STEVOR
expression on the surface of merozoites prompted us to
ask whether a differential expression of STEVOR
Figure 2 Recognition of STEVORs in non-permeabilized and saponin-permeabilized schizont infected erythrocytes (IE). (A, lower panel)
Flow cytometry histogram of non-permeabilized schizont IE recognized by the pre-immune serum (dot line) and by the anti-PFL2610w antibody
(dot-dash line). (A, upper panel) Fluorescence microscopy image of the schizont IE that were recognized by anti-PFL2610w antibody in flow
cytometry. (B, lower panel) Flow cytometry histogram of permeabilized schizont IE recognized by the anti-PFL2610w antibody (solid line). (B,
upper panel) fluorescence microscopy image of the permeabilized schizont IE recognized by anti-PFL2610w antibody in flow cytometry.
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variants take place in these parasite stages. Therefore,
SDS-soluble proteins of the early ring (8-12 h), mid-tro-
phozoite (24-30) and merozoite stages corresponding to
a single generation were analysed in a Western blot ana-
lysis using the anti-PFL2610w anti-STEVOR antibody.
A total of five STEVOR variants with variable band
intensities were identified by the antibody (Figure 5A
and Table 1) in the stages examined. Only two variants
(31.7 and 29.8 kDa) with relative band intensities of 0.56
and 0.44 respectively were identified by the anti-
PFL2610w antibody in the early ring stage parasite (Fig-
ure 5A and Table 1). The transition from ring to tro-
phozoite stage was accompanied by the expression of
three more variants (34, 28 and 25 kDa) in addition to
the two ring stage variants (31.7 and 29.8 kDa). These
two variants retained relatively higher expression levels
compared to the other variants according to the relative
band intensities estimation (Figure 5A and Table 1).
Interestingly, the development of mid-trophozoites into
schizonts for merozoite release resulted in over-expres-
sion of a single variant (31.7 kDa) in the free merozoites
(Figure 5A and Table 1). This merozoite specific variant
(31.7 kDa) was one of the five variants that seemed to
have nearly equal expression levels in the mid-tropho-
zoite stage. Possible scenarios for these differences in
the levels of expression between different stages include
stage specific upregulation of gene expression or com-
partment specific localization of the expressed proteins.
The latter scenario implies selective integration of speci-
fic STEVOR variants into merozoite membranes during
their biogenesis. To guarantee that the merozoite pre-
paration was devoid of IE membranes, merozoites were
purified by double filtering through 3 μm and 1.2 μm
Versapor membranes. This ensured that IE membranes
from ruptured schizont IE were not carried over to the
merozoite preparation. This was verified by detecting
the glycophorin A (GPA) content in the Western blot
(Figure 5B) using sample volumes identical to those
used for detecting STEVOR variants. Anti-GPA detected
only a minor quantity of GPA dimmer in the merozoite
preparation with a band intensity value of 31.5 com-
pared to 209, 201 and 166 for uninfected E, ring IE and
trophozoite IE respectively (Figure 5B). Monomeric
GPA and GPA/Glycophorin B (GPB) complex were
undetectable in the merozoite preparation (Figure 5B).
In conclusion, a single STEVOR variant appeared to be
over represented in the merozoite stage from in vitro
culture of the 3D7 P. falciparum parasite.
Discussion
Parasitic protozoa are unicellular eukaryotic pathogens
that reside in cells and/or in the extracellular fluids of
Figure 3 Colocalization of STEVORs with MSP-1 at the free
merozoite membranes. Fluorescence staining using anti-PFL2610w
and anti-MSP-1 antibodies was analysed in free merozoites. (A)
Bright field, (B) Alexa 488 stained STEVORs, (C) Alexa 594 stained
MSP-1, (D) DAPI stained parasite nuclei, (E) the overlay of STEVORs
and MSP-1 (overlay 1) and (F) the overlay of STEVORs, MSP-1 and
nuclei (overlay 2) images are shown.
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their hosts. Their success as parasite pathogens depends
on a series of complicated and highly evolved host adap-
tations that enable them to avoid destruction by the
immune system. Adoption of an intracellular life cycle is
perhaps the simplest solution for evading antibody
responses. Another major strategy that protects both
intracellular and extracellular protozoan pathogens from
immune recognition is antigenic variation of proteins
expressed on the surface of the pathogen. Plasmodium
parasites are among those protozoa that utilize both stra-
tegies. On one hand, they acquired both an intracellular
and extracellular life style and, on the other hand, they
display variant antigens on the surface of some parasite
stages. Antigenic diversity on the surface of P. falciparum
IE is well represented by PfEMP1 that undergoes anti-
genic variation while maintaining ability to cytoadhere.
There is compelling data on the exposure of this mole-
cule on the surface of the infected erythrocyte [16,17].
Other antigens also classified as P. falciparum variant
antigens are encoded by the multi-copy rif and stevor
gene families. Analogous to what has been described for
PfEMP1, original studies have reported the expression of
RIFINs, encoded by the rif gene family, in internal struc-
tures and on the surface of the late blood stages of the
parasite by the surface iodination technique [18]. While a
recent report described the expression of RIFINs in a
cap-like structure at the apical end of the merozoite [19],
additional evidence to support the previously described
surface expression of RIFINs is still lacking. STEVORs
comprising another putative variant antigen family are
expressed in the trophozoite, schizont, merozoite, game-
tocyte and sporozoite stages. They are thought to be also
displayed on the cell surface; a location that would justify
their amplification into a hypervariable multigenic family.
A recent study showed the expression of STEVOR on the
surface of late schizont using antibodies against specific
Figure 4 Detection of STEVORs on the surface of merozoites by flow cytometry. (A) Merozoite preparation stained with Giemsa. (B and C,
upper panels) Dot-plots of forward scatter (FSC) to side scatter (SSC), merozoite populations are surrounded by the R1 gate. (B and C, lower
panel) Dot-plots of Ethidium bromide- to Alexa 488-derived fluorescence of the gated populations. (C, lower panel) double-positive merozoite
population demonstrating surface exposure of STEVORs at the upper right quadrant.
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variant (PF10_0395 and PFF0850c) in flow cytometry
assays [9]. In a previous study we also showed the asso-
ciation of STEVOR with schizont IE surface by the IEM
technique [8].
In the current work, STEVORs were shown to be
expressed on the surface of the merozoite stage. This is
the first time that a variant antigen has been shown to be
expressed on the surface of extracellular P. falciparum
stage. Unexpectedly, the current study failed to detect
STEVORs on the surface of schizont IE using the anti-
PFL2610w antibody which localized STEVORs to the
surface of the merozoites. However, this antibody recog-
nized STEVORs in internal structures after permeabiliza-
tion of the schizont IE. These findings could simply
indicate that the STEVOR variants recognized by anti-
PFL2610w antibody were not exposed on the surface of
the schizont IE. Instead, other variants, if any, could be
exposed. In a previous attempt to link stevor gene
sequence diversity with surface expression STEVORs
were detected on the surface of schizont IE using antibo-
dies that were made against the conserved region only
[9]. It was suggested by the latter study that the predicted
transmembrane domain 1 is not inserted into the ery-
throcyte membrane. It was also suggested that the con-
served region and the variable loop are exposed on the
surface through anchoring of STEVOR as a single pass
membrane protein. If that were the case, the anti-
PFL2610w antibody should have recognized the surface
of the schizont IE as it was generated against both the
conserved and the variable regions. One possible expla-
nation for this conflict in reagent specificities relates to
differences between the IgG fractions in the polyclonal
antibodies that target the non-conserved epitopes on the
conserved region of STEVORs. These IgG fractions
should be also variant specific and their targets could be
more exposed on the protein and lead to limited cross-
reactivity. It is also possible that STEVORs might not be
exposed at all on the IE surface. This argument should
remain valid until further evidence on surface expression
is presented. Moreover, the noticeable expression of
STEVORs in the schizont stage may only represent a step
in the biogenesis process of the merozoite surface coat.
Thus, the presence of STEVORs in the schizont stage
does not mean that they should be exposed on the
surface because they may not function at this stage. This
resembles the appearance of MSP-1 at the schizont
periphery at 34.5 - 36 h (p.i) in the biogenesis process of
the merozoite surface coat [20] that will ultimately lead
to exposure of MSP-1 on the merozoite surface, but not
on the surface of the schizont IE.
Figure 5 Stage-specific expression of STEVORs. (A) Western blot
analysis of total protein from saponin permeabilized erythrocytes
(nE), ring IE (R), trophozoite IE (T), and merozoites (M) probed with
anti-PFL2610w. (B) A blot similar to (A) probed with anti-
Glycophorin A antibody to monitor for the presence of erythrocyte
membranes. Migration of molecular mass markers is indicated on
the left. Estimations of the molecular masses of the identified
STEVORs are indicated on the right. Abbreviations: Glycophorin A
(GPA), Glycophorin B (GPB).
Table 1 Quantification of STEVOR bands identified by the anti-PFL2610w in Western blot analysis
STEVOR variant (kDa) Ring infected erythrocytes Trophozoite infected erythrocytes Merozoites
Band intensity1 Relative intensity2 Band intensity Relative intensity Band intensity Relative intensity
34 122 0.15 62 0.09
31.7 95.20 0.56 159 0.25 181 0.65
29.8 93.60 0.44 177 0.23 72 0.19
28 155 0.18 20 0.04
25 162 0.19 17 0.03
1The intensity value at the band peak.
2The percent intensity contribution of a band within a lane.
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Stage-specific expression of STEVOR variants was
assessed by estimating the number and the level of
expression of variants identified by the anti-PFL2610w
antibody in the ring, trophozoite and merozoite stages.
The study revealed an over-expression of a specific var-
iant (31.7 kDa) in the merozoites. This finding agrees
with the postulation that the widespread expression of
STEVOR in different stages is for serving different func-
tions and indeed such a role should be played by stage-
specific variants. RIFINs represented an example on
stage-specific expression of distinct variants based on
categorization of the encoding sequences and the corre-
sponding protein localization [21]. In this report, RIFINs
were grouped into two types, the A-type RIFIN that was
found to be associated with the membrane of the IE or
the apical region of the merozoites and the B-type
RIFIN that was retained inside the parasite. Stage-speci-
fic expression of STEVOR variants based on differences
in gene or upstream sequences has not been reported so
far. In a transcription study stevor transcripts in the 3D7
trophozoites and gametocytes were similar except for a
single stevor gene that was down regulated in gameto-
cytes [22]. These findings suggest that some variants
might only be expressed in certain stages to mediate a
stage-specific function.
Moreover, an unexpected finding in the stage-specific
expression of STEVORs was the detection of STEVORs
(31.7 and 29.8 kDa) in the ring stage of the parasite.
This is in contrast to the known first appearance of ste-
vor transcripts at 22 h (p.i). It is likely that STEVORs
located on the merozoite surface could have been car-
ried into the erythrocytes during invasion and might
have persisted for some time. Similar finding was also
observed for the C-terminal 19-kDa fragment of the
MSP-1 [20,23].
In conclusion, it was shown here that STEVORs are
expressed on the surface of merozoites. This finding is
in concordance with previous studies [8,14] describing
STEVORs expression in the merozoite stage of the
P. falciparum parasite. Exposure of STEVORs on the
merozoite surface may contribute to immune escape of
merozoites for successful erythrocyte invasion.
Acknowledgements
We thank MJ Blackman, NIMR, London for anti-MSP-1 antibodies. This work
received funding from the Sigrid Jusélius foundation and the Academy of
Finland.
Authors’ contributions
AK and SM conceived and designed the experiments. AK performed the
experiments, analysed the data, and wrote the paper. SM participated in the
revision of the paper. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 26 October 2010 Accepted: 14 March 2011
Published: 14 March 2011
References
1. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI: The global distribution
of clinical episodes of Plasmodium falciparum malaria. Nature 2005,
434:214-217.
2. Marsh K, Kinyanjui S: Immune effector mechanisms in malaria. Parasite
Immunol 2006, 28:51-60.
3. Langhorne J, Ndungu FM, Sponaas AM, Marsh K: Immunity to malaria:
more questions than answers. Nat Immunol 2008, 9:725-732.
4. Schofield L, Mueller I: Clinical immunity to malaria. Curr Mol Med 2006,
6:205-221.
5. Dzikowski R, Templeton TJ, Deitsch K: Variant antigen gene expression in
malaria. Cell Microbiol 2006, 8:1371-1381.
6. Kaviratne M, Khan SM, Jarra W, Preiser PR: Small variant STEVOR antigen is
uniquely located within Maurer’s clefts in Plasmodium falciparum-
infected red blood cells. Eukaryot Cell 2002, 1:926-935.
7. Lavazec C, Sanyal S, Templeton TJ: Hypervariability within the Rifin, Stevor
and Pfmc-2TM superfamilies in Plasmodium falciparum. Nucleic Acids Res
2006, 34:6696-6707.
8. Khattab A, Bonow I, Schreiber N, Petter M, Schmetz C, Klinkert MQ:
Plasmodium falciparum variant STEVOR antigens are expressed in
merozoites and possibly associated with erythrocyte invasion. Malar J
2008, 7:137.
9. Niang M, Yan Y, Preiser PR: The Plasmodium falciparum STEVOR multigene
family mediates antigenic variation of the infected erythrocyte. PLoS
Pathog 2009, 5:e1000307.
10. McRobert L, Preiser P, Sharp S, Jarra W, Kaviratne M, Taylor MC, Renia L,
Sutherland CJ: Distinct trafficking and localization of STEVOR proteins in
three stages of the Plasmodium falciparum life cycle. Infect Immun 2004,
72:6597-6602.
11. Gardner MJ, Hall N, Fung E, White O, Berriman M, Hyman RW, Carlton JM,
Pain A, Nelson KE, Bowman S, Paulsen IT, James K, Eisen JA, Rutherford K,
Salzberg SL, Craig A, Kyes S, Chan MS, Nene V, Shallom SJ, Suh B,
Peterson J, Angiuoli S, Pertea M, Allen J, Selengut J, Haft D, Mather MW,
Vaidya AB, Martin DM, Fairlamb AH, Fraunholz MJ, Roos DS, Ralph SA,
McFadden GI, Cummings LM, Subramanian GM, Mungall C, Venter JC,
Carucci DJ, Hoffman SL, Newbold C, Davis RW, Fraser CM, Barrell B:
Genome sequence of the human malaria parasite Plasmodium
falciparum. Nature 2002, 419:498-511.
12. Lavazec C, Sanyal S, Templeton TJ: Expression switching in the stevor and
Pfmc-2TM superfamilies in Plasmodium falciparum. Mol Microbiol 2007,
64:1621-1634.
13. Sam-Yellowe TY, Florens L, Johnson JR, Wang T, Drazba JA, Le Roch KG,
Zhou Y, Batalov S, Carucci DJ, Winzeler EA, Yates JR III: A Plasmodium gene
family encoding Maurer’s cleft membrane proteins: structural properties
and expression profiling. Genome Res 2004, 14:1052-1059.
14. Blythe JE, Yam XY, Kuss C, Bozdech Z, Holder AA, Marsh K, Langhorne J,
Preiser PR: Plasmodium falciparum STEVOR proteins are highly expressed
in patient isolates and located in the surface membranes of infected red
blood cells and the apical tips of merozoites. Infect Immun 2008,
76:3329-3336.
15. Schreiber N, Khattab A, Petter M, Marks F, Adjei S, Kobbe R, May J,
Klinkert MQ: Expression of Plasmodium falciparum 3D7 STEVOR proteins
for evaluation of antibody responses following malaria infections in
naive infants. Parasitology 2008, 135:155-167.
16. Scherf A, Lopez-Rubio JJ, Riviere L: Antigenic variation in Plasmodium
falciparum. Annu Rev Microbiol 2008, 62:445-470.
17. Pasloske BL, Howard RJ: Malaria, the red cell, and the endothelium. Annu
Rev Med 1994, 45:283-295.
18. Kyes SA, Rowe JA, Kriek N, Newbold CI: Rifins: a second family of clonally
variant proteins expressed on the surface of red cells infected with
Plasmodium falciparum. Proc Natl Acad Sci USA 1999, 96:9333-9338.
19. Petter M, Haeggstrom M, Khattab A, Fernandez V, Klinkert MQ, Wahlgren M:
Variant proteins of the Plasmodium falciparum RIFIN family show distinct
subcellular localization and developmental expression patterns. Mol
Biochem Parasitol 2007, 156:51-61.
20. Margos G, Bannister LH, Dluzewski AR, Hopkins J, Williams IT, Mitchell GH:
Correlation of structural development and differential expression of
Khattab and Meri Malaria Journal 2011, 10:58
http://www.malariajournal.com/content/10/1/58
Page 9 of 10
invasion-related molecules in schizonts of Plasmodium falciparum.
Parasitology 2004, 129:273-287.
21. Petter M, Bonow I, Klinkert MQ: Diverse expression patterns of subgroups
of the rif multigene family during Plasmodium falciparum
gametocytogenesis. PLoS One 2008, 3:e3779.
22. Sharp S, Lavstsen T, Fivelman QL, Saeed M, McRobert L, Templeton TJ,
Jensen AT, Baker DA, Theander TG, Sutherland CJ: Programmed
transcription of the var gene family, but not of stevor, in Plasmodium
falciparum gametocytes. Eukaryot Cell 2006, 5:1206-1214.
23. Blackman MJ, Heidrich HG, Donachie S, McBride JS, Holder AA: A single
fragment of a malaria merozoite surface protein remains on the parasite
during red cell invasion and is the target of invasion-inhibiting
antibodies. J Exp Med 1990, 172:379-382.
doi:10.1186/1475-2875-10-58
Cite this article as: Khattab and Meri: Exposure of the Plasmodium
falciparum clonally variant STEVOR proteins on the merozoite surface.
Malaria Journal 2011 10:58.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Khattab and Meri Malaria Journal 2011, 10:58
http://www.malariajournal.com/content/10/1/58
Page 10 of 10
